Chemistry Teacher Is Now A Billionaire
A chemistry teacher turned billionaire, you may be wondering how this is possible, but one Zhong Huijuan has done it. After leaving her job as a chemistry teacher, Huijuan decided to move into the pharmaceutical business. As it turns out, it was the right call. Huijuan now has a net worth that lies in the billions.
She graduated in July of 1982 with an undergraduate in Chemistry from the Jiangsu Normal University. In the early 90s, she started her career teaching chemistry at the middle school level. However, soon after in ’95, she founded her pharma group. There is no denying that this is a truly inspiring tale of hard work, dedication, and perseverance, keep reading to find out how she was able to achieve this success.
Zhong Huijuan’s Pharmaceutical Company
Huijuan’s ‘Hansoh Pharmaceutical Group Co.’ is the sole largest manufacturer of psychotropic drugs in the People’s Republic of China. The company is all set to be introduced to the pharma market in Hong Kong with an estimated net worth of USD 10.4 billion. According to the Bloomberg Billionaires Index, since Huijuan holds about 68% of the stakes, she is entitled to a fortune of a whopping USD 7.9 billion.
The company itself researches on and is a major producer of drugs in six different types of pharmaceutical areas. Also, the company makes half of its annual revenue from their drugs that are used in cancer treatments.
This may come off as even more shocking, but Huijuan isn’t the richest person in her family as of yet. Her husband, Sun Piaoyang, is the founder of Jiangsu Hengrui Medicine Co. which has a net worth of USD 9.3 billion.
Based in Shanghai, the company excels in manufacturing anti-tumor medicines and has been established as a successful part of the pharmaceutical world for two whole decades. The couple, both 58 and 60 respectively, is all set to be dubbed as one of the world’s richest ‘pharma families’.
Future Prospects in the World of Healthcare
In recent years, it has been seen that health care budget and spending has skyrocketed in China, reaching about USD 853 billion in total from USD 3.5 billion in the calendar year of 2014. This number is further predicted to reach up to 9.4 trillion Yuan in the year 2023. Some longtime investors of Hansoh and their official spokesperson has predicted that with Hanson’s current IPO, Zhong Huijuan is all set to become the third richest person in China.
Perhaps the best thing about Hansoh’s Pharma Group is its synergy with Hengrui Medicines; the two in collaboration are bound to bring some new products in the industry. According to a Bloomberg Intelligence Analyst, the two pharma groups are mainly focusing on R&D distribution, and this is sure to bring Huijuan’s company more into the forefront. Not only that, it will allow Hansoh to have a distinct advantage of over competitors in the market so that they can make a mark!
A biotechnology and sci fi nerd, that enjoys writing about new innovations within the science world and industry.